logo

For the Inventor, By the Inventor

Chatham, NJ, United States of America

Charles F Huebner

This inventor holds 20 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Ciba-Geigy Corporation. Active years: 1976-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles F Huebner. Retrieved from https://idiyas.com/inventor/charles-f-huebner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 6

Forward Citations = 113(Granted Patents)


Location History:

  • Chatam, NJ (US) (1980)
  • Chatham, NJ (US) (1976 - 1990)

Company Filing History:

goldMedal20 out of 6,858 
 
Ciba-Geigy Corporation
 patents

Years Active: 1976-1990

Loading Chart...
Areas of Expertise:
Indoles
Piperidines
Benzodioxans
Psychostimulants
Neuroleptics
Analgesics
Hypotensive Compounds
Stereospecific Processes
Epoxybenzodioxans
2-Aminoethyl Compounds
Trimethyleneurido Compounds
Azapentane Diols
20 patents (USPTO):Explore Patents
1. 4912125 - 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles for reducing (1990-03-27),
2. 4908376 - 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles in composition form for (1990-03-13),
3. 4471128 - 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols (1984-09-11),
4. 4471127 - 1-5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols (1984-09-11),
5. 4380653 - 1,5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols (1983-04-19),
6. 4329348 - N-Oxacyclic-alkylpiperidines as psychostimulants (1982-05-11),
7. 4313955 - 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols (1982-02-02),
8. 4309349 - Stereospecific process for preparing epoxybenzodioxans (1982-01-05),
9. 4261907 - Stereospecific process (1981-04-14),
10. 4242347 - Hypotensive indolylalkylpiperidyl guanidines and isoureas (1980-12-30),
11. 4212808 - 2-Oxiranyl-1,4-benzodioxans (1980-07-15),
12. 4187313 - 2-Aminoethyl-1,4-benzodioxans (1980-02-05),
13. 4147786 - 1-Indolylalkyl-3-or 4-trimethyleneurido-piperidines (1979-04-03),
14. 4140781 - Analgesic and neuraleptic 2-piperidinoalkyl-1,4-benzodioxans (1979-02-20),
15. 4129655 - Neuroleptic 2-piperidinoalkyl-1,4-benzodioxans (1978-12-12),

Title: Charles F. Huebner: Innovator in Pharmaceutical Chemistry

Introduction

Charles F. Huebner, located in Chatham, NJ, is a notable inventor with a prolific career in pharmaceutical chemistry. With 20 patents to his name, he has contributed significantly to advancements in the field, particularly in the area of novel compounds and their therapeutic applications.

Latest Patents

Huebner's latest innovations include the patents for 2,3-dihydro-2-(4,5-dihydroimidazol-2-yl)-indoles. These compounds hold potential as α2-adrenergic blocking agents, presenting applications such as antidepressants, cognition enhancers, appetite suppressants, and intraocular pressure reducers. The detailed formulations involved in these patents describe compounds where each R can be hydrogen or lower alkyl, with variations in other substituents, allowing for a range of pharmaceutical compositions and uses.

Career Highlights

Throughout his career at Ciba-Geigy Corporation, Huebner has focused on the development of innovative pharmaceutical solutions. His work has laid the groundwork for future research and applications in cognitive and cardiovascular health, demonstrating the importance of interdisciplinary research in developing new medical therapies.

Collaborations

Huebner's work has also seen collaboration with notable colleagues, including Heinz W. Gschwend and John E. Francis. This collaborative effort has been vital in pooling expertise and resources, leading to the successful development of innovative compounds.

Conclusion

Charles F. Huebner exemplifies the innovative spirit in the realm of pharmaceutical inventions. His contributions not only enhance the scope of drug development but also provide new avenues for therapeutic interventions. As he continues to innovate within Ciba-Geigy Corporation, his pioneering work will undoubtedly influence the future of pharmaceutical chemistry and its applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…